Video Presentations

Surveying the GLP-1 Therapy Landscape Inside the Doctor's Study - Promising New Strategies in the Management of T2D: Examining the Role of the Kidney Leveraging the Physiology of Glucose Metabolism: SGLT2 Inhibitors for Treating Type 2 Diabetes The Pathogenesis of Type 2 Diabetes Evaluating Clinical Use of Long-Acting GLP-1 Therapy in Type 2 Diabetes Treatment Regimens Long-Acting GLP-1 Receptor Agonist Therapy: Improving Efficacy, Adherence, and Weight in T2DM Shared Decision Making for Clinical Success in the Obese Person with Type 2 Diabetes Clinical Shared Decision Making with the Obese Person with Type 2 Diabetes and A BMI >35 Personalized Health Risk Management and Therapeutic Decision-Making in Type 2 Diabetes Successfully Implementing Personalized Decision Making in Type 2 Diabetes Practical Opinions: Personalizing Patient Treatment Goals and Care Management in a Recently Diagnosed Type 2 Diabetes Patient Practical Opinions-Personalizing Patient Treatment Goals and Care Management in an Older Patient with Established Type 2 Diabetes Effective Use of InsulinThrough the Progression of Type 2 Diabetes - Q & A The Potential Impact of Longer-Duration GLP-1 Therapies on T2DM Treatment Approaches and Patient Outcomes Incretin Therapy in Type 2 Diabetes Applied: Navigating and Making Changes in an Ever Changing Environment Effective Use of Insulin Through the Progression of Type 2 Diabetes Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Inside the Doctor's Study: Addressing Cardiovascular Issues in Diabetes with Ralph DeFronzo Diabetes, Obesity and CVD: An Overview of the Related Physiology and Comprehensive Treatment Approaches Looking Beyond Glucose Control in Type 2 Diabetes: The Cardiovascular, Cardioprotective, and Weight Effects of GLP-1 Q&A Leveraging Weight Loss in the Treatment of Type 2 Diabetes Amylin and Pramlintide: Physiology and Its Role in the Treatment of Type 1 Diabetes, Type 2 Diabetes, and Obesity Clinical Approaches to Mimicking Normal Pancreatic Physiology Using Insulin and Amylin Replacement Therapy Biology of the Incretin Hormones Overcoming Injection Anxiety in Your Diabetes Patient
Highlights